Wellvii Receives FDA Clearance for Finger-Based BP Go Blood Pressure Monitoring

In August 2026, Wellvii received FDA clearance for its innovative BP Go blood pressure monitoring technology, a key achievement transforming remote patient monitoring and connected healthcare without a cumbersome arm cuff in clinical and home environments. Overall, it makes it easy for users to obtain and track personal health data to make more informed health decisions.

Why BP Go Blood Pressure Monitoring Technology Matters

Wellvii’s BP Go features a patented finger cuff that facilitates non-invasive blood pressure and pulse rate measurements, reducing the demand for traditional arm cuffs. This device is designed for home use and remote-care environments, primarily aligning with Wellvii’s mission to improve accessible health monitoring. 

Mark Khachaturian, Phd CEO, also emphasized that achieving FDA clearance is a major milestone for Wellvii and BP Go. This brought them closer to providing simple, accurate blood pressure monitoring to millions globally. While the company has not disclosed a launch timeline or pricing, BP Go aims to offer remote patient monitoring for individuals and healthcare providers alike.

The shift towards cuffless blood pressure monitoring is part of a broader trend, as these devices typically improve patient compliance by simplifying the measurement process. However, cuffless technologies face stringent accuracy standards, making their approval a more complex process. 

For practices leveraging remote patient monitoring, crucial considerations will include device accuracy, reimbursement, and integration with existing healthcare workflows. As more companies seek FDA clearance for non-cuff devices, physicians will prioritize validation data and compatibility with chronic care management systems.

Impact on the Healthcare Industry

This clearance positively impacts the healthcare industry by replacing cumbersome arm cuffs with a portable, clinical-grade finger-based measurement.

BP Go blood pressure monitoring technology allows the healthcare industry to boost patient compliance by leveraging the finger, wrist, or other sensor placements, eliminating the pain, awkward positioning, and friction caused by traditional inflatable arm cuffs, and encouraging regular daily measurements. It also encourages scaling remote patient monitoring and enables value-based care to actively manage chronic conditions between office visits and meet value-based care objectives.

It also helps to address industry limitations like unreliable consumer wearable claims by physically measuring pressure at the finger rather than relying on uncalibrated estimates. Additionally, it resolves cumbersome form factors and reduces workflow friction by integrating simple one-size operation with automated cloud tracking, lowering the barrier for elderly or non-tech-savvy patients to stay monitored.

Impact on the Blood Pressure Monitoring Devices Industry

The global blood pressure monitoring devices market size was estimated at USD 2.27 billion in 2025 and is anticipated to reach around USD 5.02 billion by 2035 and is poised to grow at a CAGR of 8.26% during the forecast period 2026 to 2035.

According to Precedence Research, this innovation significantly benefits the industry by replacing bulky arm cuffs with a non-invasive and finger-based measurement approach.

Blood pressure is crucial for health monitoring, especially as hypertension impacts billions of people globally. Regular measurements, typically taken once or twice a year, can be improved with BP Go, which helps to track readings over time for a clearer blood pressure reading and encourages remote hypertension monitoring to empower individuals in understanding and managing their health. Overall, by boosting compliance scales population health and improves remote care with seamless Bluetooth and cellular IoT connectivity and portability.

This further addresses various industry limitations, like lower arm cuff friction because BP Go uses a gentle finger-squeezing method, and streamlines multi-user tracking by accurately tracking individual data in multi-user environments. Furthermore, it also solves the problems related to daily calibration, unlike many consumer devices.

About Wellvii

Wellvii is an innovative health technology company that specializes in wireless, non-invasive vital sign measurement technology for consumer wellness and clinical remote patient monitoring. Wellvii’s vision is to enable the delivery of healthcare at any address through its all-in-one, comprehensive, clinically accurate, connected healthcare solution that measures 9 vital signs from the finger, including clinically accurate non-invasive blood pressure from the finger without calibration.

The Wellvii platform empowers patients and caregivers with the health stats required to drive desired clinical outcomes and develop a healthier patient population by reducing patient compliance challenges and optimizing remote chronic disease management.